Major Depressive Disorder: Diagnosis and Treatment
Medically Reviewed by Dr. M. Salar Raza | Official SCFHS 2026 Blueprint
Clinical Pathway
Major Depressive Disorder (MDD) is diagnosed when a patient experiences at least 5 of 9 typical symptoms (including depressed mood or anhedonia) for at least 2 weeks, causing significant impairment. First-line pharmacological treatment for MDD typically involves Selective Serotonin Reuptake Inhibitors (SSRIs) such as sertraline, fluoxetine, or citalopram. Cognitive Behavioral Therapy (CBT) is also a highly effective first-line psychotherapy. A combination of pharmacotherapy and psychotherapy often yields the best outcomes.
Clinical Reasoning
SSRIs are preferred as first-line agents due to their favorable side-effect profile, safety in overdose, and broad efficacy compared to older classes of antidepressants like Tricyclic Antidepressants (TCAs) or Monoamine Oxidase Inhibitors (MAOIs). It is critical to educate patients that antidepressants typically take 4-6 weeks to reach full therapeutic effect, although some improvements in sleep or appetite may be seen earlier. Patients should be closely monitored for worsening depression or emergence of suicidal ideation, particularly upon initiating therapy.
Sample MCQ
A 22-year-old college student presents to the student health center reporting a 4-week history of persistently sad mood, loss of interest in her classes and hobbies, difficulty concentrating, fatigue, and sleeping excessively. She denies any history of manic or hypomanic episodes. Which of the following is the most appropriate first-line medication class for this patient?
- ATricyclic Antidepressants (TCAs)
- BSelective Serotonin Reuptake Inhibitors (SSRIs)
- CBenzodiazepines
- DMonoamine Oxidase Inhibitors (MAOIs)
Correct Answer: Selective Serotonin Reuptake Inhibitors (SSRIs)
The patient's symptoms (sad mood, anhedonia, poor concentration, fatigue, hypersomnia) lasting for more than 2 weeks are indicative of Major Depressive Disorder (MDD). The first-line pharmacological treatment for MDD is a Selective Serotonin Reuptake Inhibitor (SSRI). SSRIs are preferred over TCAs and MAOIs due to their better tolerability and safety profile. Benzodiazepines are used for anxiety and do not treat the underlying depression.
Related Clinical Topics
Acute Otitis Media (AOM) in Pediatrics: Diagnosis and Management
Acute Otitis Media (AOM) is characterized by acute onset of symptoms (fever, ear pain) and signs of middle ear inflammation, such as a bulging tympanic membrane. The first-line antibiotic therapy for AOM is Amoxicillin, given at a high dose (80-90 mg/kg/day). Amoxicillin is effective against the most common bacterial pathogen, Streptococcus pneumoniae. If the patient has been treated with amoxicillin in the past 30 days, or has concurrent purulent conjunctivitis, Amoxicillin-clavulanate is preferred to cover beta-lactamase-producing organisms like H. influenzae.
AIDS
AIDS (Acquired Immunodeficiency Syndrome) is the final, most severe stage of HIV infection, characterized by a profoundly compromised immune system that makes individuals highly susceptible to opportunistic infections and certain cancers. It is diagnosed when the CD4+ T-cell count drops below 200 cells/mm³ or when specific AIDS-defining opportunistic illnesses develop. The cornerstone of AIDS treatment is highly active antiretroviral therapy (HAART), a combination of drugs that suppress HIV replication, preserve immune function, and prevent further progression. HAART significantly reduces viral load, increases CD4+ T-cell counts, and improves overall health. Treatment also includes prophylactic antibiotics to prevent opportunistic infections and specific therapies for any active infections or cancers. Symptoms of AIDS are primarily due to the opportunistic infections and cancers that take advantage of the severely weakened immune system. Common manifestations include persistent fever, chronic diarrhea, significant unintentional weight loss, night sweats, fatigue, swollen lymph nodes, and recurrent severe infections like Pneumocystis pneumonia, Kaposi's sarcoma, and toxoplasmosis. Neurological complications such as AIDS dementia complex can also occur.
Bradycardia
Bradycardia is a medical condition characterized by a slower than normal heart rate, typically defined as fewer than 60 beats per minute (bpm) in adults. While sometimes physiological and benign, it can also indicate underlying cardiovascular or systemic issues that impair the heart's ability to effectively pump blood. Treatment for bradycardia depends on its underlying cause, severity, and the presence of symptoms. Asymptomatic bradycardia, especially in athletes, often requires no intervention. Symptomatic bradycardia may necessitate discontinuing or adjusting causative medications, treating underlying conditions, or in severe cases, implanting a permanent pacemaker to regulate heart rhythm. Acute, unstable bradycardia may require intravenous atropine or temporary pacing. Clinical manifestations range from asymptomatic presentation to severe symptoms depending on the degree of bradycardia and the patient's cardiovascular reserve. Common symptoms include fatigue, dizziness, lightheadedness, syncope (fainting), shortness of breath, and chest pain. In critical cases, it can lead to confusion, hypotension, and signs of organ hypoperfusion.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks